Results 121 to 130 of about 29,053 (244)

124I‐labelled BMSC‐Derived Extracellular Vesicles Deliver CRISPR/Cas9 Ribonucleoproteins With a GFP‐Reporter System to Inhibit Osteosarcoma Proliferation and Metastasis

open access: yesJournal of Extracellular Vesicles, Volume 14, Issue 7, July 2025.
The fluorescence‐based Cas9 editing efficiency reporter system confirmed in vitro gene‐editing efficacy, while the radionuclide‐labelled BMSC‐derived EV delivery system demonstrated targeted in vivo distribution through radiolabel tracking. Following the validation of Cas9 RNP delivery specificity via dual‐modal imaging, subsequent mechanistic studies ...
Yujie Pan   +11 more
wiley   +1 more source

Comparative somatostatin receptor scintigraphy using In-111-DOTA-lanreotide and In-111-DOTA-Tyr3-octreotide versus F-18-FDG-PET for evaluation of somatostatin receptor-mediated radionuclide therapy

open access: bronze, 2001
Irene Virgolini   +12 more
openalex   +1 more source

Cancer‐Associated Fibroblasts: Heterogeneity, Cancer Pathogenesis, and Therapeutic Targets

open access: yesMedComm, Volume 6, Issue 7, July 2025.
Cancer‐associated fibroblasts (CAFs) arise from normal fibroblasts in response to various tumor microenvironmental signals, including cytokines such as TGF‐β and IL‐6, paracrine factors like PDGFs, Notch signaling, extracellular vesicles, as well as aging, inflammation, hypoxia, oxidative stress, and increased extracellular matrix (ECM) stiffness. Upon
Yutao Li   +6 more
wiley   +1 more source

Targeted Radionuclide Therapy Using a Wnt-Targeted Replicating Adenovirus Encoding the Na/I Symporter [PDF]

open access: green, 2009
Inge Peerlinck   +12 more
openalex   +1 more source

Instantaneous in vivo distal edge verification in intensity‐modulated proton therapy by means of PET imaging

open access: yesMedical Physics, Volume 52, Issue 7, July 2025.
Abstract Background Intensity‐modulated proton therapy (IMPT) holds promise for improving outcomes in head‐and‐neck cancer (HNC) patients by enhancing organ‐at‐risk (OAR) sparing. A key challenge in IMPT is ensuring an accurate dose delivery at the distal edge of the tumor, where the steep dose gradients make treatment precision highly sensitive to ...
Brian Zapien‐Campos   +5 more
wiley   +1 more source

Reference datasets for commissioning of model‐based dose calculation algorithms for electronic brachytherapy

open access: yesMedical Physics, Volume 52, Issue 7, July 2025.
Abstract Purpose This work provides the first two clinical test cases for commissioning electronic brachytherapy (eBT) model‐based dose calculation algorithms (MBDCAs) for skin irradiation using surface applicators. Acquisition and Validation Methods The test cases utilize the INTRABEAM 30 mm surface applicator.
Iymad R. Mansour   +12 more
wiley   +1 more source

Impact of intracellular radionuclide distribution in a Monte Carlo biophysical 3D multi‐cellular model for targeted alpha therapy

open access: yesMedical Physics, Volume 52, Issue 7, July 2025.
Abstract Background To understand and predict the therapeutic efficacy of targeted alpha therapy (TAT), nano‐ and microdosimetry are needed to consider the very heterogeneous dose deposition at cellular and subcellular levels. Purpose The objective of this study is to theoretically evaluate the importance of cell internalization of alpha‐emitters on ...
Victor Levrague   +6 more
wiley   +1 more source

Radiopharmaceuticals: From Molecular Imaging to Targeted Radionuclide Therapy

open access: diamond, 2004
P. August Schubiger   +8 more
openalex   +2 more sources

Home - About - Disclaimer - Privacy